Lexington, Massachusetts, United States
20+ years of experience within the biopharma industry leading value proposition and realization; distinctly skilled and well-networked in using data, digital and technology to improve drug development timeline and efficiency; a thought leader with numerous publications; substantial experiences engaging regulators, payers and other key stakeholders in the US, EU, and other key HTA markets; award winning performance in building successful team, leading global value, evidence & access strategies, and implementations from pre-clinical through post-commercialization; in-depth and hands-on experience and knowledge in real-world evidence (RWE) generation, health economics and outcomes research (HEOR), Bioinformatics, Machine learning/AI, and Cancer Biology
At CSD Partners, our mission is to equip our clients with a comprehensive understanding of value at the earliest stages of drug development. We aim to optimize enterprise preparedness for value assessments, while ensuring the production of robust evidence to substantiate value propositions.
Drove the overall Takeda oncology strategy on value demonstration and market access, through efforts on pricing & reimbursement, HEOR, RWE generation, stakeholder engagement, and environment shaping Served as a member of Takeda Digital Advisory Board (DAB) to drive Takeda's enterprise data, digital & technology strategy
Led Takeda Oncology evidence generation activities that captured patient needs and value expectations to support clinical development, product pricing/reimbursement, and patient access throughout the product life cycle Served as the enterprise RWE lead, driving cross-therapeutic area, cross-functional use of RWD/RWE to support regulatory, access, and commercial needs.
Served as the functional head, building the HEOR infrastructure and conducting strategic research to identify and optimize the clinical, economic, and patient-centered value that ARIAD products provide, while effectively communicating these findings to relevant internal and external audiences Drove Global Medical Affairs strategy and served as the Global Medical Affairs Lead for corporate cross-functional, cross-regional teams related to asset value proposition, communication, and stakeholder engagement